Company Data
Supernus Pharmaceuticals Inc.
Ticker
SUPN
Current Price
$33.52 -15.67%
Market Cap
$1.9B
Price Target
Refer to Report
Volume
2.2M
52wk Range
$25.53 - $40.28
Overview
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The company products include Oxtellar XR, Trokendi XR, SPN-812, and others.